AGXT Antibody

• Description:

  Alanine glyoxylate aminotransferase is expressed only in the liver and is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targeting, have been associated with type I primary hyperoxaluria. [RefSeq]

• Specifications:

  Western blot: 1:1000-1:2000

• UniProt:

  P21549

• Host:

  Mouse

• Reactivity:

  Human

• Immunogen:

  A partial recombinant protein corresponding to amino acids 188-375 from the human protein was used as the immunogen for the AGXT antibody.

• Clonality:

  Monoclonal

• Isotype:

  IgG1 k

• Clone:

  1739CT804.82.83.1

• Applications:

  WB

• Purity:

  Protein G affinity chromatography

• Format:

  Purified

• Buffer:

  In 1X PBS, pH 7.4, with 0.09% sodium azide

• Reconstitution:

  Aliquot the AGXT antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

• Limitations:

  This AGXT antibody is available for research use only.

• Storage Conditions:

  Aliquot the AGXT antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

• Formulation:

  In 1X PBS, pH 7.4, with 0.09% sodium azide

• Applications Notes:

  Titration of the AGXT antibody may be required due to differences in protocols and secondary/substrate sensitivity.

• CAS Number:

  9007-83-4

• Image Legend:

  Western blot testing of human 1) HepG2 (liver carcinoma line) and 2) liver lysate with AGXT antibody at 1:2000. Predicted molecular weight: 43 kDa.